First Niagara Bank’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-7,343
Closed -$795K 222
2015
Q3
$795K Buy
7,343
+79
+1% +$9.8K 0.21% 103
2015
Q2
$841K Sell
7,264
-149
-2% -$17K 0.19% 105
2015
Q1
$855K Buy
7,413
+48
+0.7% +$5.74K 0.19% 107
2014
Q4
$824K Sell
7,365
-151
-2% -$15.9K 0.18% 110
2014
Q3
$712K Sell
7,516
-14
-0.2% -$1.26K 0.15% 119
2014
Q2
$647K Hold
7,530
0.13% 126
2014
Q1
$526K Sell
7,530
-252
-3% -$20K 0.11% 149
2013
Q4
$657K Hold
7,782
0.13% 136
2013
Q3
$600K Sell
7,782
-1,576
-17% -$110K 0.13% 134
2013
Q2
$547K Buy
+9,358
New +$563K 0.12% 144

Other funds holding CELG

First Niagara Bank's CELG Position: Q4 2015 in Review

First Niagara Bank sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 7,343 shares — an estimated $795K sold.

First Niagara Bank first reported a position in CELG in Q2 2013 and held it in 10 quarters. The position peaked at $855K in Q1 2015. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • First Niagara Bank reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
  • First Niagara Bank sold 7,343 Celgene Corp shares in Q4 2015, an estimated $795K.
  • First Niagara Bank first reported a position in Celgene Corp in Q2 2013 and held it in 10 quarters.
  • First Niagara Bank's Celgene Corp position peaked at $855K in Q1 2015.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on First Niagara Bank's 13F filing for Q4 2015, filed 10 Feb 2016.